VBI Vaccines Inc. (VBIV)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 12:18PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 16.56M |
| Enterprise Value | 45.92M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.04 |
| Price/Book (mrq) | 2.20 |
| Enterprise Value/Revenue | 5.29 |
| Enterprise Value/EBITDA | -0.55 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.92 |
| 52-Week Change 3 | -79.14% |
| S&P500 52-Week Change 3 | 22.43% |
| 52 Week High 3 | 3.4700 |
| 52 Week Low 3 | 0.4500 |
| 50-Day Moving Average 3 | 0.6042 |
| 200-Day Moving Average 3 | 0.7523 |
Share Statistics
| Avg Vol (3 month) 3 | 466.22k |
| Avg Vol (10 day) 3 | 178.26k |
| Shares Outstanding 5 | 28.43M |
| Implied Shares Outstanding 6 | 28.43M |
| Float 8 | 26.58M |
| % Held by Insiders 1 | 7.59% |
| % Held by Institutions 1 | 11.26% |
| Shares Short (Apr 15, 2024) 4 | 709.47k |
| Short Ratio (Apr 15, 2024) 4 | 0.71 |
| Short % of Float (Apr 15, 2024) 4 | 2.69% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 2.51% |
| Shares Short (prior month Mar 15, 2024) 4 | 302.88k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Dec 28, 2012 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:30 |
| Last Split Date 3 | Apr 12, 2023 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -1,449.47% |
Management Effectiveness
| Return on Assets (ttm) | -28.57% |
| Return on Equity (ttm) | -258.99% |
Income Statement
| Revenue (ttm) | 8.68M |
| Revenue Per Share (ttm) | 0.56 |
| Quarterly Revenue Growth (yoy) | 191.10% |
| Gross Profit (ttm) | N/A |
| EBITDA | -53.32M |
| Net Income Avi to Common (ttm) | -93.84M |
| Diluted EPS (ttm) | -6.0300 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 23.68M |
| Total Cash Per Share (mrq) | 0.83 |
| Total Debt (mrq) | 53.04M |
| Total Debt/Equity (mrq) | 704.66% |
| Current Ratio (mrq) | 0.48 |
| Book Value Per Share (mrq) | 0.31 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -60.88M |
| Levered Free Cash Flow (ttm) | -39.41M |
© 2024 Yahoo. All rights reserved.